查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003178

外科潤滑劑市場：按類型、應用、最終用戶和分銷管道分類－2026-2032年全球市場預測

Surgical Lubricants Market by Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科潤滑劑市場價值將達到 7.9268 億美元，到 2026 年將成長至 8.7905 億美元，到 2032 年將達到 15.8768 億美元，年複合成長率為 10.43%。

主要市場統計數據
基準年 2025 7.9268億美元
預計年份：2026年 8.7905億美元
預測年份 2032 1,587,680,000 美元
複合年成長率 (%) 10.43%

權威概述，重點關注影響現代外科潤滑劑選擇的臨床重要性、材料創新和採購考慮因素。

儘管手術潤滑劑在現代臨床實踐中發揮著至關重要的作用，但它們的重要性卻常常被低估。手術潤滑劑能夠確保內視鏡、導管和診斷儀器的安全插入，最大限度地減少患者的不適感和手術相關併發症。聚合物化學和藥物科學的進步拓展了可用潤滑劑的種類，從傳統的礦物油基凝膠到高性能矽油和先進的水性體系，這些潤滑劑在潤滑性、生物相容性和易於消毒之間取得了平衡。如今，臨床醫生、採購負責人和監管相關人員在評估這些產品時，不僅關注其性能，還關注其與醫療設備的兼容性、感染控制通訊協定以及患者的舒適度。

關鍵的變革因素正在重塑整個外科潤滑劑生態系統的產品創新、臨床應用和合規性重點。

在技​​術創新、臨床通訊協定的不斷演進以及監管審查日益嚴格的推動下，外科潤滑劑市場正經歷一系列變革。新的配方方法強調低殘留水基體系和精準的矽油噴霧，這些產品僅在需要潤滑的部位發揮作用，同時滿足消毒和可視化的要求。同時，醫療設備設計的進步，例如微型內視鏡、軟性導管和整合式感測器陣列，對潤滑劑提出了更高的要求，即潤滑劑必須能夠維持器械的完整性，並且不會干擾成像或感測器功能。

美國於 2025 年徵收的關稅對營運和採購的累積影響正在推動來源多元化、區域韌性和供應鏈重組。

美國於2025年對進口原料和成品徵收的關稅，已對整個採購、製造和分銷管道造成了累積調整，並持續影響供應商的策略。嚴重依賴進口矽油、特殊聚合物或散裝包裝材料的製造商面臨即時的成本壓力和更長的前置作業時間，迫使他們對其採購和庫存管理實踐進行策略性重新評估。為此，許多供應商擴大了與國內供應商的合作關係，對替代原料進行認證，並增加了期貨採購，以降低關稅變化帶來的風險。

詳細的細分洞察，解釋了產品類型、臨床應用、最終用戶工作流程和分銷管道如何決定產品的適用性和採用率。

對產品細分的精準理解揭示了性能特徵和臨床工作流程如何相互作用，從而影響產品的採用。基於類型的產品區分了油基產品和矽基產品。油性產品通常配製成凝膠，適用於需要持久塗層的高潤滑應用；而矽基產品則有凝膠和噴霧劑形式，與醫療設備表面具有更廣泛的兼容性和更優異的熱穩定性。水性配方有凝膠、啫咖哩和噴霧劑形式，可滿足感染控制需求，並提供低殘留性能，以滿足內視鏡成像過程中的可視性要求。

區域趨勢和商業化策略旨在協調全球醫療保健市場的監管複雜性、臨床偏好和供應鏈彈性。

區域趨勢對監管要求、供應鏈選擇和臨床偏好產生重大影響，進而影響產品策略和商業化。在美洲，採購慣例強調建立牢固的供應商關係，遵守嚴格的臨床應用監管標準，並滿足日益成長的門診治療和微創手術製劑需求。面向該地區的製造商必須優先考慮文件記錄、上市後監測以及及時回應醫療採購委員會的要求，以確保與醫院和診所簽訂合約。

公司層面的策略，結合配方創新、監管領導力以及與銷售管道的夥伴關係，以確保在臨床環境中得到應用和供應的確定性。

企業策略體現了產品創新、嚴格的監管合規和供應鏈管理之間的平衡。領先的供應商優先考慮配方研究和臨床檢驗，以證明其產品與不斷發展的醫療設備設計和治療通訊協定的兼容性。他們投資於品質系統和文件記錄，以應對嚴格的監管檢查和採購審計，同時不斷提高生產柔軟性，以適應多種區域分銷模式並應對關稅帶來的成本壓力。

領導者可以透過結合產品創新、供應鏈彈性和與臨床醫生的合作，推動招募和營運連續性，從而採取切實可行的步驟。

產業領導者應積極整合技術、商業性和營運措施，以確保長期競爭優勢。首先，他們應優先開發符合不斷發展的臨床通訊協定的製劑組合，投資於水性、低殘留體係以及支持微創手術流程的劑型。在產品開發的同時，他們還應針對新興醫療設備平台進行嚴格的相容性測試，以減少臨床應用過程中的阻力，並支援採購核准。

嚴謹的混合方法研究設計，結合臨床醫師的訪談、技術檢驗和資料檢驗，得出實用且可操作的見解。

本分析的調查方法融合了關鍵相關人員的見解、系統性的二手文獻綜述以及結構化的檢驗，從而得出可靠的結論。主要資訊來源包括對各手術專科的臨床醫生、醫院和門診機構的採購經理以及監管和品管專家的訪談，他們提供了關於產品性能預期和採購標準的第一手觀點。除了這些定性研究之外，還與製藥科學家和醫療設備工程師進行了技術諮詢，檢驗相容性問題和應用情境的限制。

為了改善治療效果和採購決策，必須進行簡潔的整合，強調配方和醫療設備的兼容性、供應鏈的靈活性以及相關人員之間的協作。

外科潤滑劑融合了材料科學、臨床實踐和供應鏈管理，隨著手術創傷性降低和醫療設備日益複雜，其作用必將不斷擴大。配方選擇、劑型以及與臨床應用的相互作用決定了產品能否滿足手術需求，同時確保感染控制和與醫療設備的兼容性。受關稅環境和區域製造能力影響的供應鏈趨勢持續重塑籌資策略和經營模式，凸顯了整個價值鏈敏捷性和透明度的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科潤滑劑市場：按類型分類

  • 油膩的
  • 矽基
    • 凝膠
    • 噴
  • 水溶液
    • 凝膠
    • 果凍
    • 噴

第9章 外科潤滑劑市場：依應用領域分類

  • 診斷治療
  • 內視鏡檢查
    • 支氣管鏡檢查
    • 大腸鏡檢查
    • 胃鏡檢查
  • 外科手術

第10章 外科潤滑劑市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第11章 外科潤滑劑市場：依通路分類

  • 線上
  • 離線

第12章 外科潤滑劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 外科潤滑劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 外科潤滑劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國外科潤滑劑市場

第16章：中國外科潤滑劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ansell Limited
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • ConvaTec Group PLC
  • DeRoyal Industries, Inc.
  • Dynarex Corporation
  • Ecolab Inc.
  • Henry Schein, Inc.
  • Hollister Incorporated
  • McKesson Corporation
  • Mederi Therapeutics Inc.
  • Medline Industries, LP
  • MedSource Labs LLC
  • Medtronic plc
  • Stryker Corporation
  • Teleflex Incorporated
  • The Surety Rubber Company
Product Code: MRR-AD517FAA9D41

The Surgical Lubricants Market was valued at USD 792.68 million in 2025 and is projected to grow to USD 879.05 million in 2026, with a CAGR of 10.43%, reaching USD 1,587.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 792.68 million
Estimated Year [2026] USD 879.05 million
Forecast Year [2032] USD 1,587.68 million
CAGR (%) 10.43%

An authoritative introduction highlighting the clinical importance, material innovations, and procurement considerations shaping modern surgical lubricant selection

Surgical lubricants play a pivotal yet often underappreciated role in contemporary clinical practice, enabling safe insertion of endoscopes, catheters, and diagnostic devices while minimizing patient trauma and procedural complications. Advances in polymer chemistry and formulation science have expanded the range of usable agents from traditional mineral oil-based gels to high-performance silicone and advanced water-based systems that balance lubricity, biocompatibility, and ease of sterilization. Clinicians, procurement officers, and regulatory stakeholders now evaluate these products not only for performance but also for compatibility with devices, infection control protocols, and patient comfort considerations.

Consequently, clinical teams increasingly integrate product selection into procedural workflows, emphasizing formulations that reduce friction without compromising visualization or device function. Meanwhile, manufacturers focus on validation across device interfaces and regulatory pathways that prioritize safety and traceability. This introductory perspective frames the subsequent analysis by outlining the technological, clinical, and supply-side factors shaping adoption, and by highlighting the interactions between product form, application modality, and end-user requirements that determine procurement and clinical acceptance.

Key transformative forces reshaping product innovation, clinical adoption, and compliance priorities across the surgical lubricant ecosystem

The landscape for surgical lubricants is undergoing a set of transformative shifts driven by technological innovation, evolving clinical protocols, and heightened regulatory attention. New formulation approaches emphasize low-residue water-based systems and precision silicone sprays that deliver targeted lubrication while supporting sterilization and visualization requirements. At the same time, advancements in device design-smaller endoscopes, flexible catheters, and integrated sensor arrays-demand lubricants that preserve device integrity and do not interfere with imaging or sensor function.

Parallel to technological change, clinical practice patterns are shifting toward minimally invasive procedures across a broader range of indications, increasing demand for products optimized for endoscopic and ambulatory use. Regulatory frameworks and hospital procurement policies now place greater emphasis on product biocompatibility, labeling transparency, and supply chain traceability, prompting manufacturers to invest in documentation and quality systems. Together, these forces are reshaping product development priorities, clinical training protocols, and supplier relationships, with continuous innovation and compliance forming the backbone of competitive differentiation.

Cumulative operational and procurement effects of U.S. tariffs introduced in 2025 driving sourcing diversification, regional resilience, and supply-chain realignment

The introduction of tariffs affecting imported raw materials and finished goods in the United States in 2025 created a cumulative set of adjustments across procurement, manufacturing, and distribution channels that continue to influence supplier strategies. Manufacturers that relied heavily on imported silicone fluids, specialized polymers, or bulk packaging materials faced immediate cost pressures and longer lead times, prompting a strategic reevaluation of sourcing and inventory practices. In response, many suppliers expanded domestic supplier relationships, qualified alternative feedstocks, and increased forward buying to mitigate exposure to tariff volatility.

These supply-chain adjustments translated into operational trade-offs: some producers reallocated production to lower-cost facilities outside tariff-impacted supply chains, while others invested in process efficiencies to absorb additional input costs without transferring them fully to clinical buyers. Distributors and hospital procurement teams adapted by diversifying supplier panels and tightening contract terms to secure continuity. Importantly, the tariffs accelerated conversations about regional manufacturing resilience and supplier consolidation, leading to a heightened focus on transparency, dual-sourcing strategies, and nearshoring where feasible. Overall, the tariff environment catalyzed a rebalancing of cost, quality, and supply assurance priorities across the value chain.

Detailed segmentation insights explaining how formulation types, clinical applications, end-user workflows, and distribution channels determine product fit and adoption

A nuanced understanding of product segmentation clarifies how performance attributes and clinical workflows interact to shape adoption. Type-based differentiation distinguishes oil-based products, typically formulated as jelly for high-lubricity applications where long-lasting coating is desirable, from silicone-based options that appear as gel and spray formats offering compatibility with a wider range of device surfaces and favorable thermal stability. Water-based formulations, available in gel, jelly, and spray presentations, respond to infection-control preferences and offer low-residue performance that aligns with visual requirements during endoscopic imaging.

Application-focused segmentation further refines product selection by clinical context. Diagnostic procedures prioritize formulations that maintain clear visualization and reduce mucosal irritation, while surgical procedures emphasize durable lubrication that facilitates repeated instrument passes and minimizes tissue trauma. Endoscopic procedures, including bronchoscopy, colonoscopy, and gastroscopy, create distinct performance demands due to anatomical variability and device flexibility. End-user segmentation underscores operational considerations: ambulatory surgical centers and clinics often require single-use, ready-to-apply formats that support rapid turnover, while hospitals balance bulk procurement efficiencies with in-house sterilization and inventory management. Distribution channels influence accessibility and procurement workflows, with hospital pharmacies serving institutional replenishment, online sales offering direct access for specialty formulations and rapid restocking, and retail pharmacies providing point-of-care availability for outpatient and procedural clinics. Considering these intersecting segmentation dimensions reveals how formulation chemistry, delivery format, clinical application, and distribution pathways jointly determine product fit and adoption trajectories.

Regional dynamics and commercialization strategies that reconcile regulatory complexity, clinical preferences, and supply-chain resilience across global healthcare markets

Regional dynamics shape regulatory demands, supply-chain choices, and clinical preferences in ways that are consequential for product strategy and commercialization. In the Americas, procurement practices emphasize robust supplier relationships, adherence to stringent regulatory standards for clinical use, and a growing appetite for formulations that support ambulatory and minimally invasive procedures. Manufacturers targeting this region must prioritize documentation, post-market surveillance, and responsiveness to institutional buying committees to secure hospital and clinic contracts.

Overlapping regulatory frameworks and diverse healthcare infrastructures characterize Europe, Middle East & Africa, creating a complex environment where harmonized technical documentation and local regulatory expertise are critical. In this region, adoption patterns reflect both advanced tertiary care centers seeking high-performance formulations and resource-constrained settings prioritizing cost-effective, easy-to-store products. Manufacturers benefit from adaptable supply models and targeted clinical evidence to address this heterogeneity. The Asia-Pacific region combines rapid procedural volume growth with accelerated technology adoption, driving demand for scalable manufacturing, regional distribution partnerships, and products validated for a wide range of clinical settings. Across all regions, localized regulatory strategy, clinician engagement, and supply-chain resilience determine commercial success and long-term adoption.

Company-level strategies that combine formulation innovation, regulatory leadership, and channel partnerships to secure clinical adoption and supply reliability

Company strategies reflect a balance between product innovation, regulatory rigor, and supply-chain management. Leading suppliers emphasize formulation research and clinical validation to demonstrate compatibility with evolving device designs and procedural protocols. They invest in quality systems and documentation that align with stringent regulatory inspections and procurement audits, while also expanding manufacturing flexibility to serve multiple regional distribution models and address tariff-driven cost pressures.

Strategic partnerships and OEM collaborations have emerged as effective pathways to embed lubricant solutions within device ecosystems, offering bundled value propositions to hospitals and clinics. Some firms pursue focused expansion into ambulatory and outpatient channels by developing single-use, easily deployable formats and enhancing packaging for point-of-care settings. Distribution partners, including institutional pharmacies and digital channels, play an essential role in ensuring timely availability and supporting clinician education. Overall, competitive differentiation increasingly hinges on an integrated approach that combines scientific leadership, regulatory transparency, supply assurance, and targeted commercial partnerships to meet the nuanced demands of healthcare providers.

Actionable steps for leaders combining product innovation, supply-chain resilience, and clinician engagement to drive adoption and operational continuity

Industry leaders should adopt a proactive combination of technical, commercial, and operational actions to secure long-term competitive advantage. First, prioritize formulation portfolios that align with evolving clinical protocols by investing in water-based low-residue systems and delivery formats that support minimally invasive workflows. Complement product development with rigorous compatibility testing against emerging device platforms to reduce clinical adoption friction and support procurement approvals.

Second, reinforce supply-chain resilience through supplier diversification, regional manufacturing capability, and transparent traceability practices. Engage in qualified secondary sourcing for critical inputs and develop contingency inventory strategies that balance cost and service levels. Third, deepen customer engagement by offering clinician training, evidence packages, and device integration pilots that demonstrate real-world performance benefits and ease of use. Fourth, pursue strategic collaborations with device OEMs and distribution partners to create bundled solutions, streamline procurement, and accelerate adoption in ambulatory settings. Finally, align regulatory and quality investments with regional compliance requirements and post-market evidence collection to sustain trust among hospital procurement committees and clinical stakeholders. Executing these actions cohesively will position organizations to capitalize on procedural shifts while managing cost and supply risks.

A rigorous mixed-methods research design blending clinician interviews, technical validation, and data triangulation to inform practical and actionable insights

The research methodology underpinning this analysis integrates primary stakeholder insights with systematic secondary review and structured triangulation to ensure robust conclusions. Primary inputs include interviews with clinicians across procedural specialties, procurement leaders in hospitals and ambulatory settings, and regulatory and quality professionals who provide firsthand perspectives on product performance expectations and procurement criteria. These qualitative engagements were complemented by technical consultations with formulation scientists and device engineers to validate compatibility considerations and use-case constraints.

Secondary investigation drew on regulatory guidance documents, clinical procedure literature, and supply-chain reports to map material flows and compliance requirements. Data were triangulated by cross-referencing stakeholder interviews with product labeling, published clinical guidance, and distribution channel intelligence to identify consistent patterns and reconcile divergent viewpoints. Limitations include variability in institutional procurement practices and the evolving nature of regulatory guidance, which the methodology addresses through ongoing analyst validation and periodic updates to findings. Ethical standards guided all engagements, and proprietary commercial sensitivities were handled with confidentiality to preserve candid stakeholder input.

A concise synthesis emphasizing formulation-device fit, supply-chain agility, and stakeholder alignment to enhance procedural outcomes and procurement decisions

Surgical lubricants sit at the intersection of material science, clinical practice, and supply-chain management, and their role will grow as procedures become less invasive and device complexity increases. The interplay between formulation choice, delivery format, and clinical application determines how well products meet procedural demands while supporting infection control and device compatibility. Supply-chain dynamics, influenced by tariff environments and regional manufacturing capacity, continue to reshape sourcing strategies and commercial models, underscoring the need for agility and transparency across the value chain.

For decision-makers, the strategic imperative is clear: align product innovation with clinician needs, fortify supply continuity, and engage procurement stakeholders with evidence that demonstrates real-world benefits. By doing so, manufacturers and distributors can both improve procedural outcomes and create durable commercial relationships. This synthesis highlights the practical levers that stakeholders can use to respond to evolving clinical requirements and operational constraints, ensuring that lubricant selection meaningfully contributes to patient safety and procedural efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Lubricants Market, by Type

  • 8.1. Oil Based
  • 8.2. Silicone Based
    • 8.2.1. Gel
    • 8.2.2. Spray
  • 8.3. Water Based
    • 8.3.1. Gel
    • 8.3.2. Jelly
    • 8.3.3. Spray

9. Surgical Lubricants Market, by Application

  • 9.1. Diagnostic Procedures
  • 9.2. Endoscopic Procedures
    • 9.2.1. Bronchoscopy
    • 9.2.2. Colonoscopy
    • 9.2.3. Gastroscopy
  • 9.3. Surgical Procedures

10. Surgical Lubricants Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Surgical Lubricants Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Surgical Lubricants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Surgical Lubricants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Surgical Lubricants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Surgical Lubricants Market

16. China Surgical Lubricants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ansell Limited
  • 17.6. Baxter International Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Cardinal Health, Inc.
  • 17.9. ConvaTec Group PLC
  • 17.10. DeRoyal Industries, Inc.
  • 17.11. Dynarex Corporation
  • 17.12. Ecolab Inc.
  • 17.13. Henry Schein, Inc.
  • 17.14. Hollister Incorporated
  • 17.15. McKesson Corporation
  • 17.16. Mederi Therapeutics Inc.
  • 17.17. Medline Industries, LP
  • 17.18. MedSource Labs LLC
  • 17.19. Medtronic plc
  • 17.20. Stryker Corporation
  • 17.21. Teleflex Incorporated
  • 17.22. The Surety Rubber Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL LUBRICANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL LUBRICANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OIL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OIL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OIL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY JELLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY JELLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY JELLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GASTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GASTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GASTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 143. GCC SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 144. GCC SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 167. G7 SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 168. G7 SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 175. NATO SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 176. NATO SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)